The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.
Concept Life Sciences, a leading global contract research organization (CRO) specialising in integrated drug discovery, ...
Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...
Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...
Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...
Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe ...
Abcam and the other 17 members of the partnership today launched the IHI project, LIGAND-AI, to advance AI-driven drug discovery through open science.
By Sneha S K Jan 9 (Reuters) - Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results